Bank of America
RAIN

Bank of America’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bank of America’s Portfolio RAIN Stock Details RAIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,224
Closed -$23.1K – 8382
2023
Q4 		$23.1K Buy
19,224
+8,196
+74% +$8.84K ﹤0.01% 6762
2023
Q3 		$9.49K Buy
11,028
+4,132
+60% +$4.53K ﹤0.01% 6869
2023
Q2 		$8.28K Sell
6,896
-8,271
-55% -$41.4K ﹤0.01% 6905
2023
Q1 		$133K Buy
15,167
+10,827
+249% +$100K ﹤0.01% 6134
2022
Q4 		$34.7K Sell
4,340
-15,376
-78% -$96.5K ﹤0.01% 6586
2022
Q3 		$96K Sell
19,716
-20,468
-51% -$128K ﹤0.01% 6367
2022
Q2 		$223K Sell
40,184
-19,407
-33% -$66.6K ﹤0.01% 6011
2022
Q1 		$302K Buy
59,591
+2,506
+4% +$20.1K ﹤0.01% 6186
2021
Q4 		$735K Buy
57,085
+16,706
+41% +$239K ﹤0.01% 5554
2021
Q3 		$604K Buy
40,379
+39,239
+3,442% +$669K ﹤0.01% 5499
2021
Q2 		$18K Buy
+1,140
New +$20K ﹤0.01% 7174

Bank of America's RAIN Position: Q1 2024 in Review

Bank of America sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 19,224 shares — an estimated $23.1K sold.

Bank of America first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $735K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Bank of America reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 19,224 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $23.1K.
  • Bank of America first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Bank of America's Rain Oncology Inc. Common Stock position peaked at $735K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.